World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
83
Citations
34443
World Ranking
3435
National Ranking
1729

Overview

Costas A. Lyssiotis is affiliated with the University of Michigan-Ann Arbor in the United States. Their research focuses primarily on biochemistry, genetics, and molecular biology, with significant contributions to medicine. The scientist's work spans molecular biology, cancer research, oncology, immunology, and genetics as subfields of study.

The main topics of their research include:

  • Cancer, Hypoxia, and Metabolism
  • Epigenetics and DNA Methylation
  • Pancreatic and Hepatic Oncology Research
  • Glioma Diagnosis and Treatment
  • Mitochondrial Function and Pathology
  • Cancer Research and Treatments
  • Immune cells in cancer

Significant recent papers authored or coauthored by Lyssiotis cover a range of topics in cancer biology and treatment:

  • "Cysteine depletion induces pancreatic tumor ferroptosis in mice," 2020, Science
  • "Pancreatic cancer: Advances and challenges," 2023, Cell
  • "Cancer SLC43A2 alters T cell methionine metabolism and histone methylation," 2020, Nature
  • "Multimodal mapping of the tumor and peripheral blood immune landscape in human pancreatic cancer," 2020, Nature Cancer
  • "Regulatory T-cell Depletion Alters the Tumor Microenvironment and Accelerates Pancreatic Carcinogenesis," 2020, Cancer Discovery

Frequent collaborators in Lyssiotis's research include:

  • Peter Sajjakulnukit
  • Anthony Andren
  • Daniel Wahl
  • Li Zhang
  • Marina Pasca di Magliano

Lyssiotis has published extensively in several venues, with a concentration of work appearing in:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Cancer Research
  • Neuro-Oncology
  • Nature Cancer
  • Nature Communications

Best Publications

  • Oncogenic Kras maintains pancreatic tumors through regulation of anabolic glucose metabolism

    Haoqiang Ying;Alec C. Kimmelman;Costas A. Lyssiotis;Sujun Hua

  • Glutamine supports pancreatic cancer growth through a Kras-regulated metabolic pathway

    Jaekyoung Son;Costas A. Lyssiotis;Costas A. Lyssiotis;Haoqiang Ying;Xiaoxu Wang

  • Phosphoglycerate dehydrogenase diverts glycolytic flux and contributes to oncogenesis

    Jason W. Locasale;Alexandra R. Grassian;Tamar Melman;Costas A. Lyssiotis

  • Oncogene ablation-resistant pancreatic cancer cells depend on mitochondrial function

    Andrea Viale;Piergiorgio Pettazzoni;Costas A. Lyssiotis;Haoqiang Ying

  • A colorectal cancer classification system that associates cellular phenotype and responses to therapy

    Anguraj Sadanandam;Costas A Lyssiotis;Costas A Lyssiotis;Krisztian Homicsko;Krisztian Homicsko;Eric A Collisson

  • Pancreatic stellate cells support tumour metabolism through autophagic alanine secretion

    Cristovão M. Sousa;Douglas E. Biancur;Xiaoxu Wang;Christopher J. Halbrook

  • Cysteine depletion induces pancreatic tumor ferroptosis in mice.

    Michael A. Badgley;Daniel M. Kremer;H. Carlo Maurer;H. Carlo Maurer;Kathleen E. DelGiorno

  • ERK1/2-dependent phosphorylation and nuclear translocation of PKM2 promotes the Warburg effect

    Weiwei Yang;Yanhua Zheng;Yan Xia;Haitao Ji

  • Metabolic Interactions in the Tumor Microenvironment

    Costas A. Lyssiotis;Alec C. Kimmelman

  • Influence of Threonine Metabolism on S-Adenosylmethionine and Histone Methylation

    Ng Shyh-Chang;Jason W. Locasale;Jason W. Locasale;Costas A. Lyssiotis;Costas A. Lyssiotis;Yuxiang Zheng

  • Oxidative stress controls regulatory T cell apoptosis and suppressor activity and PD-L1-blockade resistance in tumor.

    Tomasz Maj;Wei Wang;Wei Wang;Joel Crespo;Hongjuan Zhang

  • Combination of ERK and autophagy inhibition as a treatment approach for pancreatic cancer

    Kirsten L. Bryant;Clint A. Stalnecker;Daniel Zeitouni;Jennifer E. Klomp

  • A regenerative approach to the treatment of multiple sclerosis

    Vishal A. Deshmukh;Virginie Tardif;Costas A. Lyssiotis;Chelsea C. Green

  • MUC1 and HIF-1alpha Signaling Crosstalk Induces Anabolic Glucose Metabolism to Impart Gemcitabine Resistance to Pancreatic Cancer.

    Surendra K. Shukla;Vinee Purohit;Kamiya Mehla;Venugopal Gunda

  • Reprogramming of murine fibroblasts to induced pluripotent stem cells with chemical complementation of Klf4

    Costas A. Lyssiotis;Ruth K. Foreman;Judith Staerk;Michael Garcia

  • Combining a PI3K Inhibitor with a PARP Inhibitor Provides an Effective Therapy for BRCA1-Related Breast Cancer

    Ashish Juvekar;Laura N. Burga;Hai Hu;Elaine P. Lunsford

  • Cancer SLC43A2 alters T cell methionine metabolism and histone methylation.

    Yingjie Bian;Wei Li;Daniel M. Kremer;Peter Sajjakulnukit

  • Phosphoinositide 3-Kinase Regulates Glycolysis through Mobilization of Aldolase from the Actin Cytoskeleton

    Hai Hu;Ashish Juvekar;Costas A. Lyssiotis;Evan C. Lien

  • Multimodal mapping of the tumor and peripheral blood immune landscape in human pancreatic cancer

    Nina G. Steele;Eileen S. Carpenter;Samantha B. Kemp;Veerin R. Sirihorachai

  • Employing Metabolism to Improve the Diagnosis and Treatment of Pancreatic Cancer

    Christopher J. Halbrook;Costas A. Lyssiotis

Frequent Co-Authors

Lewis C. Cantley
Lewis C. Cantley Harvard University
John M. Asara
John M. Asara Beth Israel Deaconess Medical Center
Marina Pasca di Magliano
Marina Pasca di Magliano University of Michigan–Ann Arbor
Alec C. Kimmelman
Alec C. Kimmelman New York University
Peter G. Schultz
Peter G. Schultz Scripps Research Institute
Howard C. Crawford
Howard C. Crawford University of Michigan–Ann Arbor
Haoqiang Ying
Haoqiang Ying The University of Texas MD Anderson Cancer Center
Yatrik M. Shah
Yatrik M. Shah University of Michigan–Ann Arbor
David B. Lombard
David B. Lombard University of Michigan–Ann Arbor

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Costas A. Lyssiotis

Trending Scientists